The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Probing The Gene-Environment Interaction In Metabolic Disease
Funder
National Health and Medical Research Council
Funding Amount
$863,910.00
Summary
A major problem with modern medicine is it is based on the law of averages, assuming everybody responds in the same way to a drug or a diet. In view of the diversity between humans as a function of genetic, epigenetic and other factors this is not the case. In the clinic there is marked variation in the response to drugs commonly used to treat patients with type 2 diabetes. This proposal seeks to embrace this complexity to develop a precision medicine approach to future medical care.
Molecular Mechanisms Of Protein Function And Pharmacology In Neuroscience And Cancer
Funder
National Health and Medical Research Council
Funding Amount
$876,005.00
Summary
I have been a Fellow 19 years. It allows me to think strategically on a broader canvass. I am a world authority in endocytosis (how cells interact with the outside world), drug discovery, and protein function, in disciplines of neuroscience and cancer. The outcome will be the first human trials of endocytosis modulators in cancer and epilepsy. Secondly, we will use our new International ProCan Centre to produce a transformational rapid cancer diagnostic and provide new cancer treatment options.
Biomarkers For The Diagnosis And Prognostic Analysis Of Male Infertility
Funder
National Health and Medical Research Council
Funding Amount
$631,370.00
Summary
Male infertility is a common condition, affecting 1 in 15 men. Although a standard semen analysis is often performed to test whether a man is infertile, it is far from definitive. We have developed a new approach, by looking at proteins that are commonly missing from infertile sperm cells. From this analysis, we can definitively diagnose male infertility and are beginning to understand why men are becoming infertile.
Defining The Role Of The PSA-related Kallikrein Serine Proteases In Hormone Dependent Cancer Progression
Funder
National Health and Medical Research Council
Funding Amount
$880,454.00
Summary
Kallikreins are a family of 15 proteins, related to the prostate cancer biomarker PSA, that have potential as biomarkers for hormone dependent cancers such as prostate and ovarian cancer. Prof Judith Clements and her team discovered that kallikreins induce resistance to chemotherapy in ovarian cancer and are found in prostate cancer bone disease. Her research will determine the underlying mechanisms of kallikrein action and their potential as new biomarkers or treatment targets for these disease ....Kallikreins are a family of 15 proteins, related to the prostate cancer biomarker PSA, that have potential as biomarkers for hormone dependent cancers such as prostate and ovarian cancer. Prof Judith Clements and her team discovered that kallikreins induce resistance to chemotherapy in ovarian cancer and are found in prostate cancer bone disease. Her research will determine the underlying mechanisms of kallikrein action and their potential as new biomarkers or treatment targets for these diseases.Read moreRead less
The Role Of Maternal Asthma In The Health Of Mother, Fetus And Child
Funder
National Health and Medical Research Council
Funding Amount
$621,458.00
Summary
A/Prof Clifton is a world leader in the area of maternal asthma and pregnancy. Her strengths relate to the fact that she can interface between basic science and the clinic in order to change clinical practice and policy. She consistently publishes her work and is regularly invited as a plenary speaker. She is a recognised leader in her field by her many prestigious appointments. She was awarded an outstanding mentor award 2011 in recognition of her contribution to student supervision and staff m ....A/Prof Clifton is a world leader in the area of maternal asthma and pregnancy. Her strengths relate to the fact that she can interface between basic science and the clinic in order to change clinical practice and policy. She consistently publishes her work and is regularly invited as a plenary speaker. She is a recognised leader in her field by her many prestigious appointments. She was awarded an outstanding mentor award 2011 in recognition of her contribution to student supervision and staff mentoring.Read moreRead less
Biochemistry And Cell Biology Of Antigen Presentation And T Cell Activation
Funder
National Health and Medical Research Council
Funding Amount
$763,409.00
Summary
José Villadangos studies the cells and molecules involved in Antigen Presentation. This phenomenon consists of the detection, capture and display of microbe fragments on the surface of Antigen Presenting Cells (APC) for recognition by T cells. This initiates an immune response that culminates in the deployment of cells and molecules armed to fight the infection. His research may lead to development of more effective vaccines and prevention of autoimmunity, allergy and transplant rejection.
Identification Of Novel Treatment Strategies For Human Cancers Through Integrative Phosphoproteomics And Kinomics.
Funder
National Health and Medical Research Council
Funding Amount
$763,409.00
Summary
This proposal aims to use new cutting-edge techniques to characterize, at a global level, changes in growth regulatory signals in cancer cells. This will identify proteins critical for cancer growth that represent potential targets for therapy. In addition it will highlight ways to select the most effective treatments for individual patients. The ultimate outcome of this work will be improved treatment strategies for cancer patients, and hence reduced morbidity and mortality.
Understanding Determinant Selection In Autoimmune Diseases
Funder
National Health and Medical Research Council
Funding Amount
$686,656.00
Summary
Understanding what the immune system perceives during infection or in autoimmunity is key to the development of improved vaccines and therapies for a variety of human diseases. This proposal builds on leading research into the definition of targets of immunity in autoimmune diseases using cutting edge proteomic technologies. The proposal focuses on type 1 diabetes, multiple sclerosis, lupus and rheumatoid arthritis and will delineate candidate therapeutic molecules.